Corticosteroids Market to Grow with a CAGR of 4.92% through 2030
The
rising adoption of corticosteroid-based therapies for respiratory diseases and
the advancement in corticosteroid formulations for better efficacy, is
expected to drive the Global Corticosteroids Market growth in the forecast
period, 2026-2030
According to
TechSci Research report, “Corticosteroids Market – Global Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2030F”, the
Global Corticosteroids Market stood at USD
6.14 Billion in 2024 and is expected to reach USD 8.20 Billion by
2030 with a CAGR of 4.92% during the forecast period. The Global
Corticosteroids Market continues to experience robust growth, primarily driven
by the increasing demand for effective treatments for a wide range of
conditions such as allergies, respiratory diseases, and autoimmune disorders.
Corticosteroids are considered the first-line therapy for many of these
conditions due to their powerful anti-inflammatory properties. The growing
incidence of conditions like chronic obstructive pulmonary disease (COPD) and
psoriasis is accelerating the adoption of corticosteroid therapies. Advances in
drug delivery systems, such as inhalers and topical creams, have made it easier
for patients to use corticosteroids more effectively, leading to higher
adoption rates. Furthermore, the increasing focus on inflammation-related
diseases as a major health concern is contributing to market expansion.
The market is
also witnessing a shift towards new corticosteroid drugs that focus on
improving safety profiles and minimizing adverse effects such as weight gain,
high blood pressure, and osteoporosis. Innovations in the pharmaceutical
industry, such as the development of long-acting corticosteroid formulations,
are gaining popularity for their convenience and effectiveness. Moreover, the
expanding focus on immunotherapy and biologic drugs has opened new avenues for
corticosteroid use, especially in combination therapies. These trends are
enhancing the appeal of corticosteroids, as they work synergistically with
other treatments to address a broader range of complex diseases, leading to
better patient outcomes.
A key growth
opportunity in the Global Corticosteroids Market lies in the expansion of
corticosteroid use in emerging markets. These regions are witnessing an
increase in the prevalence of diseases requiring corticosteroid treatments,
such as asthma and rheumatoid arthritis, due to lifestyle changes and
urbanization. Companies can tap into these regions by introducing affordable
and accessible corticosteroid therapies. Furthermore, there is potential for
strategic partnerships between pharmaceutical companies and healthcare
providers to increase patient awareness and improve access to essential
corticosteroid treatments. This collaboration could lead to the development of
more patient-centric therapies, including personalized corticosteroid
treatments, based on genetic and environmental factors, further driving market
expansion.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Corticosteroids Market”
The Global Corticosteroids
Market is segmented into type, route of administration, application, regional
distribution, and company.
Based on the Application,
Acute Respiratory Diseases emerged as the fastest growing segment in the Global
Corticosteroids Market during the forecast period. This is due to the rising
prevalence of respiratory conditions such as asthma, chronic obstructive
pulmonary disease (COPD), and pneumonia. Acute respiratory diseases are
becoming increasingly common due to factors such as pollution, smoking,
lifestyle changes, and an aging population. Corticosteroids are essential in
managing these conditions, especially during acute exacerbations, as they help
reduce inflammation in the airways and improve respiratory function. The
growing incidence of asthma attacks and COPD flare-ups, particularly in urban
areas with higher pollution levels, is directly contributing to the higher
demand for corticosteroid-based treatments. Moreover, the rise in global
awareness regarding respiratory health, combined with improvements in
healthcare infrastructure, has led to better diagnosis and treatment options
for respiratory diseases. Corticosteroids, especially inhaled formulations, have
become standard in managing asthma and COPD symptoms, resulting in better
control of the diseases. As healthcare providers continue to emphasize early
intervention and effective management of respiratory conditions, the demand for
corticosteroids in acute respiratory diseases is projected to grow rapidly in
the coming years.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
Corticosteroids Market during
the forecast period. This is due to several key factors. First, the region is
experiencing a rapid increase in the prevalence of respiratory diseases,
allergies, and autoimmune conditions, which are often treated with
corticosteroids. The rising levels of air pollution, changing dietary habits,
and growing urbanization are contributing to higher rates of asthma, chronic
obstructive pulmonary disease (COPD), and other respiratory illnesses in
countries like China and India, driving the demand for corticosteroids. Asia-Pacific
has a large and aging population, which is more susceptible to conditions that
require corticosteroid treatment, such as rheumatological disorders and
endocrine imbalances. Healthcare systems in the region are improving, leading
to greater access to medical treatments, including corticosteroids, and a
rising number of healthcare facilities offering advanced treatment options.
The
region also benefits from increasing healthcare awareness and government
initiatives to improve healthcare access, particularly in emerging economies.
As pharmaceutical companies continue to expand their presence in Asia-Pacific,
there is a growing availability of corticosteroid products, both in branded and
generic forms, which is further propelling the market growth. With these
factors combined, Asia-Pacific is expected to witness the highest growth in the
corticosteroids market.
Major
companies operating in Global Corticosteroids Market are:
- AbbVie
Inc.
- AstraZeneca
plc
- Bayer
AG
- Eli
Lilly and Company
- F.
Hoffmann-La Roche Ltd.
- GlaxoSmithKline
plc
- Merck
& Co., Inc.
- Novartis
International AG
- Pfizer
Inc.
- Sanofi
S.A.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The Global Corticosteroids Market is expanding
due to the growing awareness and acceptance of corticosteroid treatments among
healthcare professionals and patients, particularly in the management of
autoimmune diseases. As more patients are diagnosed with conditions like
multiple sclerosis and lupus, the demand for corticosteroids as an essential
part of their treatment plans is increasing. Healthcare providers are becoming
more confident in prescribing corticosteroids for their anti-inflammatory and
immunosuppressive properties, which are critical in controlling disease
flare-ups and managing symptoms. As the understanding of these drugs' benefits
in autoimmune therapy improves, the market is experiencing accelerated growth.,”
said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Corticosteroids Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By
Type (Glucocorticoids, Mineralocorticoids), By Route of Administration
(Inhaled, Topical, Injectable, Oral), By Application (Skin Allergies,
Gastroenterology, Endocrinology, Acute Respiratory Diseases, Rheumatology
Indications, Others), By Region and Competition, 2020-2030F”,
has evaluated the future growth potential of Global Corticosteroids Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Corticosteroids Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com